Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Taipei Exchange - Delayed Quote TWD

Lin BioScience, Inc. (6696.TWO)

Compare
117.50
+4.00
+(3.52%)
As of 11:23:08 AM GMT+8. Market Open.
Advanced Chart
Loading Chart for 6696.TWO
  • Previous Close 113.50
  • Open 115.00
  • Bid 117.00 x --
  • Ask 118.00 x --
  • Day's Range 115.00 - 118.50
  • 52 Week Range 70.00 - 180.50
  • Volume 119,016
  • Avg. Volume 355,060
  • Market Cap (intraday) 9.714B
  • Beta (5Y Monthly) -0.05
  • PE Ratio (TTM) --
  • EPS (TTM) -9.45
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Lin BioScience, Inc., a drug development company, develops therapies for oncology, ophthalmology, and metabolic diseases. Its product pipeline includes LBS-008, an oral therapy for dry age-related macular degeneration (Dry AMD)and stargardt diseases (STGD1), which is under Phase 3 clinical trial to evaluate safety and efficacy in adolescent STGD1 and under phase 2 or phase 3 clinical trial to evaluate safety and efficacy in Dry AMD; LBS-007, a natural non-ATP CDC7 inhibitor for the treatment of cancers; LBS-002, an anti-tubulin to treat primary and metastatic brain tumors; and LBS-009, an oral therapy for the treatment of non-alcoholic fatty liver disease and type 2 diabetes. The company is headquartered in Taipei, Taiwan.

www.linbioscience.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

More about Lin BioScience, Inc.

Recent News: 6696.TWO

View More
View More

Performance Overview: 6696.TWO

Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .

YTD Return

6696.TWO
14.55%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
13.84%

1-Year Return

6696.TWO
46.88%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
2.94%

3-Year Return

6696.TWO
53.44%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
16.72%

5-Year Return

6696.TWO
94.12%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
89.98%

Compare To: 6696.TWO

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

6696.TWO
Lin BioScience, Inc.
117.50
+3.52%
Mkt Cap TWD 9.714B
Industry Biotechnology
BLTE
Belite Bio, Inc
58.61
+3.55%
Mkt Cap 1.892B
Industry Biotechnology
4178.TWO
StemCyte International, Ltd.
30.15
-0.17%
Mkt Cap TWD 5.79B
Industry Biotechnology
7759.TWO
SUNHAWK BIO
98.30
-1.59%
Mkt Cap TWD 6.888B
Industry Biotechnology
6564.TWO
Enimmune corporation
19.00
+0.26%
Mkt Cap TWD 1.369B
Industry Biotechnology
6634.TWO
Sinew Pharma Inc.
47.15
-0.74%
Mkt Cap TWD 3.362B
Industry Biotechnology
6976.TWO
Acepodia, Inc.
16.70
+1.21%
Mkt Cap TWD 9.513B
Industry Biotechnology
7808.TWO
BIONET TX Corp
45.15
+1.14%
Mkt Cap TWD 3.161B
Industry Biotechnology
6610.TWO
TWi Biotechnology, Inc.
10.25
-1.44%
Mkt Cap TWD 945.016M
Industry Biotechnology
6748.TWO
ACRO Biomedical Co., Ltd.
35.85
+2.14%
Mkt Cap TWD 2.195B
Industry Biotechnology
6885.TW
BRIM Biotechnology, Inc.
23.80
+2.59%
Mkt Cap TWD 3.15B
Industry Biotechnology

Statistics: 6696.TWO

View More

Valuation Measures

Annual
As of 4/14/2025

  • Market Cap

    9.42B

  • Enterprise Value

    5.30B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    3.71

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -23.80%

  • Return on Equity (ttm)

    -37.51%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -731.66M

  • Diluted EPS (ttm)

    -9.45

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.17B

  • Total Debt/Equity (mrq)

    0.86%

  • Levered Free Cash Flow (ttm)

    -743.86M

View More

Research Analysis: 6696.TWO

View More
View More

Company Insights: 6696.TWO

Research Reports: 6696.TWO

View More
View More

People Also Watch

4157.TWO TaiGen Biopharmaceuticals Holdings Limited
9.50
+2.15%
 
6547.TWO Medigen Vaccine Biologics Corporation
44.25
+3.63%
 
6712.TWO Ever Supreme Bio Technology Co., Ltd
167.50
+3.72%
 
4743.TWO Oneness Biotech Co., Ltd.
62.50
+5.76%
 
4174.TWO OBI Pharma, Inc.
49.10
+1.87%
 
6541.TW Tanvex BioPharma, Inc.
62.90
+5.18%
 
3176.TWO Medigen Biotechnology Corp.
29.00
+4.32%
 
6589.TWO EirGenix Inc.
63.20
+1.94%
 
4142.TW Adimmune Corporation
18.40
+2.22%
 
6617.TWO Gongwin Biopharm Holdings Co., Ltd.
80.50
+5.09%
 
4726.TWO Mycenax Biotech Inc.
31.90
+2.41%
 
6576.TWO Foresee Pharmaceuticals Co., Ltd.
65.50
+3.14%
 
1760.TW Panion & Bf Biotech Inc.
67.00
+2.29%
 
4162.TWO PharmaEngine, Inc.
89.00
+4.58%
 
4147.TWO TaiMed Biologics Inc.
77.90
+0.91%
 
6634.TWO Sinew Pharma Inc.
47.15
-0.74%